Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DE:KRUE Price & Analysis
KRUE ETF Chart & Stats
Day’s Range― - ―
52-Week Range€8.55 - €12.62
Previous Close€9.04
VolumeN/A
Average Volume (3M)681.00
AUM1.50M
NAV9.98
Expense Ratio0.65%
Holdings Count61
Beta0.39
Inception DateJan 14, 2021
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume681
AlphaN/A
ETF Overview
KraneShares MSCI All China Health Care Index UCITS ETF AccumUSD
The Fund seeks to deliver the performance of publically traded China-based companies whose primary business is in the healthcare and healthcare-related sectors and whose securities are listed in Hong Kong, Shanghai, Shenzhen and outside of China (the China Healthcare Companies)
KraneShares MSCI All China Health Care Index UCITS ETF AccumUSD (KRUE) Fund Flow Chart
KraneShares MSCI All China Health Care Index UCITS ETF AccumUSD (KRUE) 1 year Net Flows: -€505K
KRUE ETF News
PremiumCompany Announcements
CSPC Pharmaceutical’s New Drug Wins China Approval
PremiumCompany Announcements
CSPC’s New Cancer Drug Accelerates Through FDA Fast Track
PremiumCompany Announcements
Sino Biopharmaceutical Signs Key Drug Deal
PremiumCompany Announcements
Sino Biopharmaceutical Buys Back SharesSee More DE:KRUE News
KRUE ETF FAQ
What was DE:KRUE’s price range in the past 12 months?
DE:KRUE lowest ETF price was €8.55 and its highest was €12.62 in the past 12 months.
What is the AUM of DE:KRUE?
As of Aug 20, 2024 The AUM of DE:KRUE is 1.50M.
Is DE:KRUE overvalued?
According to Wall Street analysts DE:KRUE’s price is currently Undervalued.
Does DE:KRUE pay dividends?
DE:KRUE does not currently pay dividends.
How many shares outstanding does DE:KRUE have?
Currently, no data Available
Which hedge fund is a major shareholder of DE:KRUE?
Currently, no hedge funds are holding shares in DE:KRUE
Top 10 Holdings
U.S. Dollar
100.00%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A
8.04%
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
7.21%
BeiGene Ltd
6.56%
CSPC Pharmaceutical Group
4.18%
Innovent Biologics
4.03%
Wuxi Biologics (Cayman)
3.72%
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A
3.28%
Sino Biopharmaceutical
2.82%
WuXi AppTec Co., Ltd. Class A
2.70%
Total142.54%
See All Holdings